NCT04311463 Bioequivalence Study of Paroxetine and PAXIL Under Fasting Conditions in Healthy Mexican Participants Status COMPLETED Phase PHASE1
NCT04295733 Safety, Tolerability and Immunogenicity of 4CMenB Vaccine(2 Doses) in Adults With an Immunodeficiency Status COMPLETED Phase N/A
NCT04292912 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema Status TERMINATED Phase PHASE1
NCT04276233 Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma Status COMPLETED Phase PHASE4
NCT04267939 ATR Inhibitor Elimusertib (BAY1895344) Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian Cancer Status TERMINATED Phase PHASE1
NCT04246047 Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04240106 Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-,ER+) and gBRCA or HDR+ Metastatic Breast Cancer (LUZERN) Status COMPLETED Phase PHASE2
NCT04237896 Compliance With Clinical Guidelines and Effect on Patient Outcome of Treatment of Hospitalised Exacerbations of COPD Status UNKNOWN Phase N/A
NCT04224701 A Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein BG505 SOSIP.GT1.1 Gp140 Vaccine, Adjuvanted in Healthy, HIV-uninfected Adults Status COMPLETED Phase PHASE1
NCT04187144 Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI) Status COMPLETED Phase PHASE3
NCT04184336 Enhanced Population-based Core Surveillance of Meningococcal Invasive Infections at Participating Centers Across Canada Status UNKNOWN Phase N/A
NCT04179032 Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04177823 A Study of Belantamab Mafodotin to Investigate Safety, Tolerability, Pharmacokinetics, Immunogenicity and Clinical Activity in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) Status COMPLETED Phase PHASE1
NCT04176939 A Study to Test GlaxoSmithKline's (GSK) Herpes Zoster (HZ) Subunit Vaccine's Long-term Immune Response in Previously Vaccinated Kidney Transplant Adults and Then to Test if 2 Additional Doses of the Vaccine Are Safe and Able to Generate an Immune Response Status COMPLETED Phase PHASE3
NCT04167358 Linerixibat Long-term Safety, and Tolerability Study Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04162210 Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04151225 Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease Status WITHDRAWN Phase PHASE2